Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2017-09-21 to 2022-12-31
Current total value of award: $262985.58
Description: PILOT STUDY OF DENOSUMAB IN BRCA1/2 MUTATION CARRIERS SCHEDULED FOR RISK-REDUCING SALPINGO-OOPHERECTOMY